Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Cystic Fibrosis and COVID-19: Care Considerations. Respiratory medicine case reports Mirza, A. A., Rad, E. J., Mohabir, P. K. 2020: 101226

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well as alterations to routine CF care at a large academic center. Key considerations include accessible COVID-19 screening, augmented infection control practices, and rapid integration of telemedicine.

View details for DOI 10.1016/j.rmcr.2020.101226

View details for PubMedID 32953446

View details for PubMedCentralID PMC7492163